ABBV AbbVie Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ABBV

Price (delayed)

$221.23

Market cap

$390.87B

P/E Ratio

108.98

Dividend/share

$6.74

EPS

$2.03

Enterprise value

$454.33B

?
Relative Growth: Rel. Growth: 31
Relative Strength: Rel. Strength: 46
Relative Valuation: Rel. Valuation: 16
Relative Profitability: Rel. Profitability: 51

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. On October 19, 2011, Abbott Laboratories announced its plan to separate ...

Highlights
The quick ratio has grown by 27% from the previous quarter and by 8% YoY
ABBV's revenue is up by 10% year-on-year and by 2.7% since the previous quarter
ABBV's P/E is 93% above its 5-year quarterly average of 56.8 but 6% below its last 4 quarters average of 116.4
AbbVie's equity has plunged by 102% from the previous quarter
The EPS has contracted by 14% from the previous quarter and by 14% YoY
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: https://www.abbvie.com/
Peers: PFE BMY LLY AMGN

Key stats

What are the main financial stats of ABBV

ABBV stock price

How has the AbbVie stock price performed over time
Intraday
-0.56%
1 week
-1.65%
1 month
5.15%
1 year
19.27%
YTD
-3.18%
QTD
1.72%

Financial performance

How have AbbVie's revenue and profit performed over time
Revenue
$62.82B
Gross profit
$44.4B
Operating income
$15.33B
Net income
$3.64B
Gross margin
70.7%
Net margin
5.8%
The operating income has soared by 52% YoY
The operating margin rose by 39% year-on-year
The net margin has declined by 21% year-on-year and by 16% since the previous quarter
The company's net income fell by 14% QoQ and by 13% YoY

Price vs fundamentals

How does ABBV's price correlate with its fundamentals

Growth

What is AbbVie's growth rate over time

Valuation

What is AbbVie stock price valuation
ABBV P/E details
P/E
108.98
P/B
N/A
P/S
6.23
EV/EBIT
52.74
EV/EBITDA
27.29
EV/Sales
7.23
ABBV's P/E is 93% above its 5-year quarterly average of 56.8 but 6% below its last 4 quarters average of 116.4
The EPS has contracted by 14% from the previous quarter and by 14% YoY
AbbVie's equity has plunged by 102% from the previous quarter
ABBV's P/S is 21% above its 5-year quarterly average of 5.2
ABBV's revenue is up by 10% year-on-year and by 2.7% since the previous quarter

Efficiency

How efficient is AbbVie business performance
AbbVie's ROIC has increased by 37% YoY but it has decreased by 7% from the previous quarter
The ROS has grown by 32% YoY but it has contracted by 9% from the previous quarter
AbbVie's return on assets has decreased by 13% QoQ and by 10% YoY

Dividends

What is ABBV's dividend history
Dividend details
DPS
$6.74
Dividend yield
3.05%
Payout ratio
332%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did AbbVie financials performed over time
AbbVie's total assets is 4.7% lower than its total liabilities
The quick ratio has grown by 27% from the previous quarter and by 8% YoY
ABBV's current ratio is up by 19% since the previous quarter and by 5% year-on-year
The company's debt to equity has shrunk by 122% YoY but it rose by 47% QoQ
AbbVie's equity has plunged by 102% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.